For security purposes
FOR SECURITY PURPOSES - because Internet Explorer is no longer supported by Microsoft, we suggest that you interact with our secure site through one of our supported browsers - Google Chrome, Firefox, or MS Edge. If you continue to use this website with Internet Explorer you do so at your own risk and you may encounter problems.
search
Applications
KNX 5 Brochure - Pharma mix analysis using Kinetex 5um C18 150x4.6mm
20738
Separation Mode: Reversed Phase
Reversed Phase
C18
HPLC
Anti-Inflammatory Agents, Non-Steroidal
Pharmaceutical/Biopharmaceutical

Applications

KNX 5 Brochure - Pharma mix analysis using Kinetex 5um C18 150x4.6mm
zoom_in
Analytes
1Procainamide
2Acetaminophen
3Folic acid
4Sulfathiazole
5Acebutolol
6Dextromethorphan
7Diphenhydramine
8Propafenone
9Amitriptyline
10Fluoxetine
11Naproxen
12Diflunisal
13Indomethacin
Compound Name
Procainamide
CID
4913
Molecular Formula
C13H21N3O
Molecular Weight
235
No. Hydrogen Bond Acceptors
3
No. Hydrogen Bond Donors
2
Details
LC Conditions (App ID: 20738)
Column:
Brand Name:
Kinetex
Part No:
Phase Name:
C18
Elution Type:
Gradient
Mobile Phase:
A: Water with 0.1% TFA
B: Acetonitrile with 0.1% TFA
Gradient Profile:
Step No.Time(min)%A%B
10955
215595
Flow Rate:
1.2 mL/min
Temperature:
22°C
Detection:
UV-Vis Abs.-Variable Wave.(UV) @ 254 nm (22°C)

Order Items Used in This Application

Similar Applications
search
Kinetex 5 µm C18 100 Å, LC Column 100 x 4.6 mm, Ea
Reversed Phase
Phenomenex logo
Phenomenex is a technology leader committed to developing novel analytical chemistry solutions that solve the separation and purification challenges of researchers worldwide.
CONNECT WITH US

PRODUCTS AND SERVICES

Products

Techniques

Industries

Quick Order

SUPPORT 

Product/Method Support

Product Troubleshooting

Contact Us

CQA / CofA


OUR COMPANY

About Phenomenex

News

Blog

Danaher Life Sciences


Terms and Conditions Privacy Statement Quality Policy Terms of Use Trademarks CA Supply Chains Act CA Consumer Privacy Act Cookie Policy Impressum © 2023 Phenomenex Inc. All rights reserved.